ExaCare AI
AI NativeIndustry-leading AI agents for faster admissions, smarter reimbursement, and better outcomes in skilled nursing.
Est 2022|Valuation $228M|Raised $36.5M
Published Oct 7, 2026
The vendor site contains several testimonials and outcome claims, including estimates of additional revenue or time-savings. These are vendor-published claims and are not independently validated; attribution details and measurement methodology are not consistently disclosed in public materials.
Positive themes (limited sample):
Negative themes (limited sample):
From the vendor's positioning and testimonials:
Public independent review volume is low, so churn reasons are not well-documented. Plausible churn drivers include:
Best fit appears to be multi-facility SNF operators and organizations with centralized admissions—operators with multiple sites and sufficient referral volume to justify automation.
Get a comprehensive analysis of ExaCare AI including market position, competitive landscape, adoption trends, and peer benchmarks.
Download full report →Capterra
Summary of reviewer comments (paraphrased for neutral tone):
G2
Examples from the vendor site include claims such as:
Critical evaluation:
ExaCare AI is an admissions and operations workflow platform that uses artificial intelligence technologies, focused on post-acute care—particularly skilled nursing facilities (SNFs) and related referral-driven settings. The product is described by the vendor as a system that:
Core operational objectives appear to be: reduce time-to-review, increase speed-to-respond, admit better-fit patients, and protect reimbursement/margins. Vendor materials emphasize admissions acceleration, reimbursement automation, and automated AI components.
Vendor-reported outcomes include time savings per referral, weekly hours saved per facility, and increased admissions. These outcomes are presented on product pages and marketing content; the public materials reviewed do not disclose methodology or independent validation.